Moderna Inc
NASDAQ:MRNA
Other Pre-Announcement
Moderna Expects Its Covid-19 Vaccine To Be Protective Against Variants Of Coronavirus Recently Described In UK
Published: 12/23/2020 23:39 GMT
Moderna Inc (MRNA) - Moderna Inc - Statement on Variants of Sars-cov-2 Virus.
Moderna -range of Potential Neutralizing Antibodies Provide Confidence Covid-19 Vaccine Will Be Effective at Inducing Neutralizing Antibodies Against Any Strain.
Moderna - Tested Sera From Animals, Humans Vaccinated With Co's Covid-19 Vaccine Against Number of Prior Variants of Virus That Emerged Since Outbreak.
Moderna - Expects Vaccine-induced Immunity Co's Covid-19 Vaccine Would Be Protective Against Variants of Sars-cov-2 Virus Recently Described in the Uk.
Moderna - Will Be Performing Additional Tests of Co's Covid-19 Vaccine in Coming Weeks to Confirm Expectation Against Variants of Virus Described in Uk.
Moderna -range of Potential Neutralizing Antibodies Provide Confidence Covid-19 Vaccine Will Be Effective at Inducing Neutralizing Antibodies Against Any Strain.
Moderna - Tested Sera From Animals, Humans Vaccinated With Co's Covid-19 Vaccine Against Number of Prior Variants of Virus That Emerged Since Outbreak.
Moderna - Expects Vaccine-induced Immunity Co's Covid-19 Vaccine Would Be Protective Against Variants of Sars-cov-2 Virus Recently Described in the Uk.
Moderna - Will Be Performing Additional Tests of Co's Covid-19 Vaccine in Coming Weeks to Confirm Expectation Against Variants of Virus Described in Uk.